AbbVie Inc.: cash_and_equivalents
| Value | {"amount": 10000000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2010-12-31) |
| Status | current |
| Entity | AbbVie Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:44:34.547090+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5109584c-ccf9-418a-b333-2c73467f24fd
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001047469-14-001154Retrieved: 2026-08-19T15:44:34.547090+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001551152/cash-and-equivalents/2010-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5109584c-ccf9-418a-b333-2c73467f24fd
History
- no predecessors — first report